No Data
No Data
Earnings Preview: Rogers to Report Financial Results Post-market on October 24
Roche Receives FDA Approval for the First Companion Diagnostic to Identify Patients With Gastric and Gastroesophageal Junction Cancer Eligible for Targeted Treatment With VYLOY
Express News | Roche Receives FDA Approval for the First Companion Diagnostic to Identify Patients With Gastric and Gastroesophageal Junction Cancer Eligible for Targeted Treatment With Vyloy
Baylin Technologies Announces Deployment of Multibeam Antennas for Upcoming High-Profile Events at Rogers Stadium, Toronto and BC Place, Vancouver
Manifest Meets Gen Z Where They Are With Launch of New Self-Empowerment Wellness App
Rogers Communication (RCI) Reports Next Week: Wall Street Expects Earnings Growth